Ryman Healthcare enjoyed its best week in almost two years.
The Australian-owned company’s underlying earnings have fallen 88%.
Listed transport company reports solid revenue and profit growth in half year.
Managing director indicates potential for capital return after executing investment strategy.
Revenue and profit grows at infant formula marketer, but no news on deployment of $1b cash balance.
The wool carpet maker has initiated strategic review amid buyer interest.
The ASX-listed company behind a biomass project needs more than $300m to develop a plant at Kawerau.
Australian media report Zuru co-founder was weighing bid for NZ Herald publisher.
‘Someone else can have sleepless nights and check the weather forecast at 4am to see if there’s a frost in Martinborough.’
Low expectations for earnings will turn attention to company forecasts.
